Endogenous cell metabolism and different chemicals, drugs, ionising radiation, solar light, cigarette smoking, and air pollution can induce oxidative damage to DNA. Oxidative DNA damage is involved in the development of different diseases, aging, and cancer. Urine 8-hydroxy-2'deoxyguanosine (8-oxodG) is widely accepted as a biomarker of the "whole body" oxidative DNA damage. The aim of this study was to introduce a method for determination 8-oxodG in spot urine samples using high-performance liquid chromatography with electrochemical detection. In the tested range of 50 nmol L -1 to 400 nmol L 
Chemicals, drugs, ionising radiation, solar light, cigarette smoking, and air pollution can increase the production of reactive oxygen species (ROS). ROS is a product of metabolism and causes damage to DNA and another macromolecules such as lipids and proteins. Oxidative DNA damage can lead to cancer, aging, and degenerative diseases (1) . Although more than 20 different oxidative modifications of DNA bases have been identified, the major product of DNA oxidative damage is 8-hydroxyguanine (8-oxoG) and its nucleoside 8-hydroxy-2'deoxyguanosine (8-oxodG). 8-oxodG has widely been accepted as a biomarker of DNA damage and cellular oxidative stress (2) . Its appearance in urine is the consequence of DNA-repair mechanism in the cell. It is excreted via urine without metabolising any further. Thus, the urinary excretion of 8-oxodG reflects oxidative DNA damage and the "whole body" repair of DNA (3, 4) .
The assessment of urine 8-oxodG involves a noninvasive method for the evaluation of oxidative DNA damage that could be correlated with exposure to ROS-inducing agents. 8-oxodG is stable in frozen urine for an extended period, and recent studies in humans reveal that the concentration of urine 8-oxodG does not depend on nucleic acid in diet (5) .
Since urine concentration of 8-oxodG is very low, and urine as such is a complex matrix, measurement of 8-oxodG in urine is an analytical challenge. Several methods for determination of 8-oxodG have been proposed such as gas chromatography -mass spectrometry, enzyme-linked immunosorbent assay, liquid chromatography -mass spectrometry, and high-performance capillary electrophoresis. As 8-oxodG oxidises readily, high performance liquid chromatography with electrochemical detection (HPLC-EC) can detect it even at low levels. The electrochemical detection of 8-oxodG has been shown to be three orders of magnitude more sensitive than UV detection (6) .
The aim of this study was to develop a reliable HPLC-EC method for determination of 8-oxodG in a complex biological matrix such as urine. For this purpose, we tested different clean-up procedures, different mobile phase compositions, and analytical columns from different suppliers. 
MATERIALS AND METHODS

Chemicals
Chromatographic conditions
The mobile phase consisted of 50 mmol L 
Electrochemical conditions
The electrochemical flow cell has a three-electrode configuration: a glassy carbon working electrode, an in situ Ag/AgCl reference electrode (ISAAC), and a stainless steel auxiliary electrode. The ISAAC reference electrode needs less potential than the salt bridge Ag/AgCl electrode, but requires mobile phase that contains 2 mmol L -1 KCl. The cell potential was set at +0.6 V. The analytical column and flow cell were kept in a Faraday-shielded oven compartment, and the temperature was set at 30 °C.
Sample preparation
Morning spot urine samples were obtained randomly from apparently healthy individuals (N=6). Different urine clean-up procedures on different cartridges were tested (2, (6) (7) (8) .
Bond Elut C18 cartridges were used following the procedure of Samcova et al. (6) and Rebelo et al. (2) . Following the first procedure, cartridges were preconditioned with 5 mL methanol, followed by 5 mL water. Two millilitres of the supernatant of centrifuged urine (1500 g, 10 min.), one sample spiked with known concentration of 8-oxodG aqueous standard and one not, were applied to the cartridge under no excess of vacuum. The cartridge was then washed with 3 mL of 6 % methanol and 6 mL of water. 8-oxodG was eluted from the cartridge with 10 % acetonitrile. The eluted sample was evaporated to dryness under a stream of N 2 . Before injection to the HPLC, the sample was dissolved in 0.5 mL water. The same type of cartridges was used following the procedure of Rebelo et al. (2) . Cartridges were preconditioned with 6 mL of methanol, followed by 3 mL of water and 6 mL of phosphate buffer (50 mmol L -1 , pH 6.1). Three millilitres of the supernatant of centrifuged urine (one sample spiked with known concentration of 8-oxodG and one not), prepared as described above, were applied to the cartridges. Cartridges were washed with 3 mL of phosphate buffer (50 mmol L -1 , pH 6.1). 8-oxodG was eluted with 3 mL of 20 % methanol in phosphate buffer (50 mmol L -1 , pH 6.1). Aliquots of the eluted solution were directly injected to the HPLC.
The next clean-up procedure was performed on Bond Elut C18 OH cartridges preconditioned with 10 mL methanol, followed by 10 mL of water (7). Urine samples were acidified (pH 4-5) and centrifuged as in previous procedures, and 2 mL of the supernatant of urine (one sample spiked with known 8-oxodG concentration and one not) were applied to cartridges. The cartridges were washed with 5 mL of water and 8-oxodG was eluted with 2 mL 30 % methanol. Before injection to HPLC eluted sample was evaporated to dryness and dissolved in 0.5 mL of water.
The third type of cartridges, Bond Elute Certify, was tested for the clean-up of urine sample according to the Spinosa de Martinis and Pires Bicanchi method (8) with some modifications. The cartridges were preconditioned with 10 mL methanol, 5 mL water, and 10 mL phosphate buffer (0.1 mmol L -1 , pH 6.0). An aliquot of 2.0 mL of urine (one sample spiked with known 8-oxodG concentration and one not) was applied to the cartridge. The cartridge was washed with 3 mL water and dried under full vacuum for 10 min. 8-oxodG was eluted with 1 mL phosphate buffer (0.1 mmol L -1 , pH 6.0). The elute was evaporated to dryness, and after dissolving in 0.5 mL of water, injected to the HPLC. Urine 8-oxodG was quantified by measuring peakareas on the linear regression curve for aqueous standard solutions (50 nmol L -1 , 100 nmol L -1 , 200 nmol L -1 , and 400 nmol L -1 ).
RESULTS AND DISCUSSION
Literature is not conclusive about the importance of the pH of the mobile phase in 8-oxodG measurement. Most authors used acidic mobile phase (pH=3.5) (6, 9), while other reported that the tested pH range of 4.5-7 was not relevant for the retention time of 8-oxodG on the analytical column (C18) (2). We found that there was no difference in the retention time and in recovery (peak size) of 8-oxodG when we used mobile phases of either pH 4.45 or 3.5. Experimental values for 8-oxodG pK are scarce, but some results indicating that 8-oxodG is neutral below pH 8 may explain the independence of the retention time and recovery from the pH of the mobile phase. Although pH does not affect the retention time and peak size of 8-oxodG, methanol (the organic part of the mobile phase) shifts the retention time of the peak. An increase in methanol content also lowers the background current.
The best results were obtained with a mobile phase that consisted of 50 mmol L -1 KH 2 PO 4 , 2 mmol L -1
KCl, 2.5 % acetonitrile, and 1 % methanol, with final pH of 4.45. The flow rate was adjusted according literature data to 0.5 mL min -1 . To analyse urine 8-oxodG, we used the reversephase mode. As nucleotides are often too hydrophilic to be separated with standard (silica-based) C18 ODS columns, nucleosides are detected instead (10) . We tested two C18 reverse-phase analytical columns from different suppliers. Asahipak ODP-50 4D column has a low-polarity, polymer-based packing material with octadecyl groups. With this column, separation was low and peaks tailed. Microsorb 100-5 BDS column is declared to minimise tailing for small charged molecules. Because of ionic interactions between charged compounds and charged silanols at the surface of the silica on a C18 column, the peaks of charged compounds are tailed. With this column the separation of the peaks was better.
Higher potential enhances electrochemical reaction and increases the analyte's signal, that is, sensitivity is greater, but so is interference. The choice of the working potential is a compromise between sensitivity, selectivity, and reproducibility. In order to find the optimal working potential for 8-oxodG, we made a hydrodynamic voltammogram (known as the I-E curve), which describes the currentvoltage relationship. We established the I-E curve by running several chromatograms of the same 8-oxodG concentration (1 µmol L -1 ) at different working potentials (E=+0.4 V to +0.7 V) (Figure 1 ). The optimal working potential was +0.6 V.
On the Microsorb 100-5 BDS column and mobile phase containing 50 mmol
KCl, 2.5 % acetonitrile, and 1 % methanol, with the flow rate of 0.5 mL min -1 , the retention time of 8-oxodG was around 13 minutes ( Figure 2) . The calibration curve for calculating 8-oxodG concentrations was prepared from working standards in the concentration range from 50 nmol L -1 to 400 nmol L -1 . The curve was linear (r 2 =0.9995), and the curve slope was y=0.03x±1.76. The limit of detection calculated by taking the average noise signal and adding three standard deviations of noise was 3 nmol L -1
. Reproducibility (day-to-day precision) was below 5 % R.S.D.
Most common cartridges used for urine clean-up are the hydrophobic, silica-based C18 cartridges, because they retain most organic analytes from aqueous matrices. In our study, three different cartridges for urine clean-up were tested.
Two different clean-up procedures on Bond Elut C18 (2, 6) did not sufficiently purify the sample for HPLC analysis, and some other compounds were co-eluted at the retention time of 8-oxodG. The third clean-up procedure was tested using the nonendcapped version of the C18 cartridge, that is, C18 OH (7). The results were similar even though producers declare that the non-endcapped version of the octadecyl-bonded phases is more active in the retention of the basic compounds and that the 150A intermediate pore size is good for intermediate-weight compounds. The third cartridge was an endcapped C8 column, which is usually used to desalt aqueous matrices for the analysis of small to intermediate molecules, but which we used to clean urine samples. A modified method of Spinosa de Martinis and Pires Bianchi for cleaning urine gave the best separation of peaks (8) .
In our study, the calculated 8-oxodG concentrations in spot urine samples (N=6) collected from healthy individuals ranged between 3.0 nmol L -1 and 48.0 nmol L -1 . Our results support another study reporting a range between 2.4 nmol L -1 and 93.3 nmol L -1 in urine of 60 healthy non-smokers (9) . In most studies, using various methods, the reported values of 8-oxodG concentrations in urine were below 30 nmol L -1 (corresponding to 10 ng mg -1 of creatinine) (2) . Despite analytical difficulties associated with the clean-up, urine 8-oxodG measurement has the following advantages over the measurement of oxidative DNA damage in tissue: it is a non-invasive method, 8-oxodG is not artificially produced during isolation of DNA, and it is stable during urine storage and assay. The measurement of DNA base products excreted into the urine reflects well oxidative DNA damage in the whole organism. , {to odgovara vrijednostima u zdravim ispitanicima u drugim istra`ivanjima. 
